EDAP, developer of promising medical devices for HIFU and ESWL treatments, has been buffeted by hospitals concentrating on treating Covid-19 patients. However, this looks like postponement to us, with little long-term damage to the company’s perspectives, which remain bright. We therefore see the 50%+ correction in the share price as an opportunity. Source: (Exclusive) The […]
Entries Tagged as 'EDAP'
May 5th, 2020 · Comments Off on (Exclusive) The Selloff In EDAP Looks Overdone
October 7th, 2019 · Comments Off on EDAP Is At An Inflection Point
The company is in the first inning with its HIFU treatment of prostate cancer, enjoying near triple-rate growth in Q2. Its other business is more steady, but also had a good quarter. Given the growth, the large margin expansion and profitability, and the additional HIFU treatment opportunities further away in time we think the shares […]